DE1204363B - Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt - Google Patents

Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt

Info

Publication number
DE1204363B
DE1204363B DEH53530A DEH0053530A DE1204363B DE 1204363 B DE1204363 B DE 1204363B DE H53530 A DEH53530 A DE H53530A DE H0053530 A DEH0053530 A DE H0053530A DE 1204363 B DE1204363 B DE 1204363B
Authority
DE
Germany
Prior art keywords
acid
resistant
juice
ileum
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEH53530A
Other languages
German (de)
English (en)
Inventor
Dr Kurt Muenzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1204363B publication Critical patent/DE1204363B/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DEH53530A 1963-09-10 1964-08-14 Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt Pending DE1204363B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1115563 1963-09-10

Publications (1)

Publication Number Publication Date
DE1204363B true DE1204363B (de) 1965-11-04

Family

ID=4370622

Family Applications (1)

Application Number Title Priority Date Filing Date
DEH53530A Pending DE1204363B (de) 1963-09-10 1964-08-14 Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt

Country Status (10)

Country Link
US (1) US3431338A (enExample)
BE (1) BE652807A (enExample)
BR (1) BR6462426D0 (enExample)
DE (1) DE1204363B (enExample)
DK (1) DK112191B (enExample)
ES (1) ES303909A1 (enExample)
FR (1) FR4213M (enExample)
GB (1) GB1017674A (enExample)
IL (1) IL21981A (enExample)
NL (1) NL6410434A (enExample)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419722A1 (fr) * 1978-03-13 1979-10-12 Bayer Italia Spa Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus
DE3331262A1 (de) * 1982-08-30 1984-03-01 Being-Well Products Inc., 07606 South Hackensack, N.J. Ernaehrungssupplement mit zielgebietsfreigabe
US4786505A (en) * 1986-04-30 1988-11-22 Aktiebolaget Hassle Pharmaceutical preparation for oral use
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US8603520B2 (en) 2003-06-26 2013-12-10 Intellipharmaceutics Corp. Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US9078827B2 (en) 2006-05-12 2015-07-14 Isa Odidi Pharmaceutical composition having reduced abuse potential
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
US10799460B2 (en) 2011-09-07 2020-10-13 Roland SAUR-BROSCH Formulation for the controlled release of one or several substances in the digestive tract of a mammal

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US4965089A (en) * 1989-04-10 1990-10-23 Sauter Manufacturing Corp. Method and apparatus for the gelatin coating of caplets
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
AU689250B2 (en) 1994-04-22 1998-03-26 Astellas Pharma Inc. Colon-specific drug release system
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
CA2609617C (en) * 2005-05-31 2014-07-08 The Iams Company Feline probiotic lactobacilli
AR053805A1 (es) * 2005-05-31 2007-05-23 Iams Company Bifidobacterias probioticas para felinos
RU2309731C1 (ru) * 2006-09-29 2007-11-10 Исаак Григорьевич Гитлин Гранулят эметина гидрохлорида, способ его получения и лекарственная форма на его основе
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957804A (en) * 1958-06-06 1960-10-25 Harlan R Shuyler Pesticide

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419722A1 (fr) * 1978-03-13 1979-10-12 Bayer Italia Spa Procede d'obtention de microgranules de substances pharmaceutiques, gastro-resistants et enterosolubles et microgranules ainsi obtenus
DE3331262A1 (de) * 1982-08-30 1984-03-01 Being-Well Products Inc., 07606 South Hackensack, N.J. Ernaehrungssupplement mit zielgebietsfreigabe
US4786505A (en) * 1986-04-30 1988-11-22 Aktiebolaget Hassle Pharmaceutical preparation for oral use
LT3699B (en) 1986-04-30 1996-02-26 Haessle Ab Pharmaceutical preparation for oral use
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
US6479075B1 (en) 1997-10-06 2002-11-12 Isa Odidi Pharmaceutical formulations for acid labile substances
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8603520B2 (en) 2003-06-26 2013-12-10 Intellipharmaceutics Corp. Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US9636306B2 (en) 2003-06-26 2017-05-02 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9078827B2 (en) 2006-05-12 2015-07-14 Isa Odidi Pharmaceutical composition having reduced abuse potential
US10632205B2 (en) 2006-05-12 2020-04-28 Intellipharmaceutics Corp Pharmaceutical composition having reduced abuse potential
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology
US10799460B2 (en) 2011-09-07 2020-10-13 Roland SAUR-BROSCH Formulation for the controlled release of one or several substances in the digestive tract of a mammal

Also Published As

Publication number Publication date
NL6410434A (enExample) 1965-03-11
ES303909A1 (es) 1965-07-16
GB1017674A (en) 1966-01-19
BE652807A (enExample) 1965-03-08
DK112191B (da) 1968-11-18
US3431338A (en) 1969-03-04
IL21981A (en) 1968-02-26
FR4213M (enExample) 1966-06-13
BR6462426D0 (pt) 1973-08-07

Similar Documents

Publication Publication Date Title
DE1204363B (de) Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
EP0032562B1 (de) Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
EP0069259B1 (de) Bromhexin-Retardform und Verfahren zu ihrer Herstellung
DE69817587T2 (de) Aus einer vielzahl von kleineinheiten aufgebaute brausedosisform
DE2414868C3 (de) Teilchenförmige Arzneimittel
DE69800419T2 (de) Kapsel mit verlängerter Wirkstofffreisetzung und Verfahren zu ihrer Herstellung
DE69331906T2 (de) Granulierte pharmazeutische zusammensetzung
DE3783394T2 (de) Arzneizubereitung zur oralen anwendung.
DE60003396T2 (de) Bupropion-darreichungsform mit kontrollierter freisetzung
DE2010416A1 (de) Oral anwendbare Arzneiform mit Retardwirkung
EP0934058B1 (de) Stabile arzneiform mit benzimidazolderivaten als wirkstoff zur oralen verabreichung und verfahren zu ihrer herstellung
DE2336218A1 (de) Neue orale arzneiform und verfahren zu ihrer herstellung
DE3707571A1 (de) Verfahren zur herstellung von granulaten, das geeignet ist zur produktion von zur lang andauernden freisetzung beschichteten tabletten zur oralen verwendung
DE3815562A1 (de) Pharmazeutische zusammensetzung
DD298205A5 (de) Verfahren zum herstellen von langzeitwirkenden arzneimittelzubereitungen
CH659584A5 (de) Wirkstoffspender mit aus einem semipermeablen bestandteil und einem magensaftresistenten bestandteil gebildeter wand.
DE69011618T2 (de) Mundzubereitung zur verabreichung an bestimmter stelle des darmes.
DE69008107T2 (de) Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs.
DE602006000819T2 (de) Dipyridamol enthaltende Zusammensetzungen mit verlängerter Freisetzung und Verfahren zu deren Herstellung
EP2679216B1 (de) Arzneiform zur modifizierten Freisetzung von Betahistin
JPH0624962A (ja) 腸溶徐放性製剤
IE56604B1 (en) Pinacidil-containing preparations
DE2328580A1 (de) Arzneimittelformulierung mit kontrollierter verweilzeit im gastrischen bereich
US20130209554A1 (en) Novel gelatin capsule compositions and methods of making
DE69904465T2 (de) Therapie von depressionen